APO Research
Talk to an analyst

APO RESEARCH · REPORT

OTC Drug and Dietary Supplement

Compare research editions
View pricing & licenses

Selected research

Market Structure

Global OTC Drug and Dietary Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032

31 December 2025196 pages

Choose your research edition.

Industry ResearchOTC Drug and Dietary Supplement Industry Research Report 2026117 pages · $2,950 USDIndustry Growth & TrendsGlobal OTC Drug and Dietary Supplement Industry Growth and Trends Forecast to 2032101 pages · $3,450 USDMarket StructureGlobal OTC Drug and Dietary Supplement Market by Size, by Type, by Application, by Region, History and Forecast 2021-2032196 pages · $3,950 USDMarket Outlook & Growth OpportunitiesGlobal OTC Drug and Dietary Supplement Market Outlook and Growth Opportunities 2026195 pages · $4,250 USDMarket Analysis & ForecastGlobal OTC Drug and Dietary Supplement Market Analysis and Forecast 2026-2032195 pages · $4,950 USD

Market perspective

The global OTC Drug and Dietary Supplement market was valued at US$ million in 2026 and is projected to reach US$ million by 2032, implying a CAGR of xx% over 2026-2032.

The US & Canada market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The Europe market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Read the full market overview

The Asia Pacific market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

The China market for OTC Drug and Dietary Supplement is projected to increase from US$ million in 2026 to US$ million by 2032, at a CAGR of % over 2026-2032.

Leading global manufacturers of OTC Drug and Dietary Supplement include Abbott, Pfizer, GSK, Bayer, Suntory, Reckitt Benckiser, Herbalife, Glanbia and Blackmores, among others. In 2025, the top three vendors together accounted for approximately % of global revenue.

Report Includes

This report provides an overview of the global OTC Drug and Dietary Supplement market and its size, analyzing global market trends based on historical revenue data for 2021-2025, estimates for 2026, and projected CAGRs through 2032.

The study covers key producers of OTC Drug and Dietary Supplement and revenue in major regions and countries, assesses future market potential, and highlights priority regions and countries for segmenting the market into sub-sectors, with country-specific market value data for the U.S., Canada, Mexico, Brazil, China, Japan, South Korea, Southeast Asia, India, Germany, the U.K., Italy, the Middle East, Africa, and other countries.

The report also presents OTC Drug and Dietary Supplement revenue, market share, and industry ranking for the main manufacturers for 2021-2026, identifies the major stakeholders in the global market, and analyzes their competitive landscape and market positioning based on recent developments and segmental revenues.

In addition, the report analyzes segment data by Type and Application—covering revenue and growth rates—for 2021-2032, and evaluates and forecasts the OTC Drug and Dietary Supplement market size, projected growth trends, production technologies, key applications, and end-use industries.

OTC Drug and Dietary Supplement Segment by Company

Abbott

Pfizer

GSK

Bayer

Suntory

Reckitt Benckiser

Herbalife

Glanbia

Blackmores

Amway

OTC Drug and Dietary Supplement Segment by Type

Powders

Capsules

Tablets

Liquids

OTC Drug and Dietary Supplement Segment by Application

Convenience Stores

Supermarkets

Pharmacies

OTC Drug and Dietary Supplement Segment by Region

North America

United States

Canada

Europe

Germany

France

U.K.

Italy

Netherlands

Asia-Pacific

China

Japan

South Korea

India

Australia

China Taiwan

Southeast Asia

South America

Mexico

Brazil

Argentina

Middle East & Africa

Turkey

Saudi Arabia

UAE

Study Objectives

1. To analyze and research the global status and future forecast, involving, production, value, consumption, growth rate (CAGR), market share, historical and forecast.

2. To present the key manufacturers, capacity, production, revenue, market share, and Recent Developments.

3. To split the breakdown data by regions, type, manufacturers, and Application.

4. To analyze the global and key regions market potential and advantage, opportunity and challenge, restraints, and risks.

5. To identify significant trends, drivers, influence factors in global and regions.

6. To analyze competitive developments such as expansions, agreements, new product launches, and acquisitions in the market.

Reasons to Buy This Report

1. This report will help the readers to understand the competition within the industries and strategies for the competitive environment to enhance the potential profit. The report also focuses on the competitive landscape of the global OTC Drug and Dietary Supplement market, and introduces in detail the market share, industry ranking, competitor ecosystem, market performance, new product development, operation situation, expansion, and acquisition. etc. of the main players, which helps the readers to identify the main competitors and deeply understand the competition pattern of the market.

2. This report will help stakeholders to understand the global industry status and trends of OTC Drug and Dietary Supplement and provides them with information on key market drivers, restraints, challenges, and opportunities.

3. This report will help stakeholders to understand competitors better and gain more insights to strengthen their position in their businesses. The competitive landscape section includes the market share and rank (in volume and value), competitor ecosystem, new product development, expansion, and acquisition.

4. This report stays updated with novel technology integration, features, and the latest developments in the market.

5. This report helps stakeholders to gain insights into which regions to target globally.

6. This report helps stakeholders to gain insights into the end-user perception concerning the adoption of OTC Drug and Dietary Supplement.

7. This report helps stakeholders to identify some of the key players in the market and understand their valuable contribution.

Chapter Outline

Chapter 1: Introduces the report scope of the report, executive summary of different market segments (product type, application, etc), including the market size of each market segment, future development potential, and so on. Revenue of OTC Drug and Dietary Supplement in global and regional level. It provides a quantitative analysis of the market size and development potential of each region and its main countries and introduces the market development, future development prospects, market space, and capacity of each country in the world. It offers a high-level view of the current state of the market and its likely evolution in the short to mid-term, and long term.

Chapter 2: Analysis key trends, drivers, challenges, and opportunities within the global OTC Drug and Dietary Supplement industry.

Chapter 3: Detailed analysis of OTC Drug and Dietary Supplement companies' competitive landscape, revenue, market share and industry ranking, latest development plan, merger, and acquisition information, etc.

Chapter 4: Provides the analysis of various market segments by type, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different market segments.

Chapter 5: Provides the analysis of various market segments by application, covering the revenue, and development potential of each market segment, to help readers find the blue ocean market in different downstream markets.

Chapter 6: Provides profiles of key companies, introducing the basic situation of the main companies in the market in detail, including product descriptions and specifications, OTC Drug and Dietary Supplementrevenue, gross margin, and recent development, etc.

Chapter 7: North America (US & Canada) by type, by application and by country, revenue for each segment.

Chapter 8: Europe by type, by application and by country, revenue for each segment.

Chapter 9: China by type, and by application, revenue for each segment.

Chapter 10: Asia (excluding China) by type, by application and by region, revenue for each segment.

Chapter 11: South America, Middle East & Africa by type, by application and by country, revenue for each segment.

Chapter 12: Concluding Insights of the report.

More report detail

Tables and figures
List of Tables Table 1. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type (US$ Million): 2021 VS 2025 VS 2032 Table 2. Key Players of Powders Table 3. Key Players of Capsules Table 4. Key Players of Tablets Table 3. Key Players of Liquids Table 4. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Application (US$ Million): 2021 VS 2025 VS 2032 Table 5. Key Players of Convenience Stores Table 6. Key Players of Supermarkets Table 7. Key Players of Pharmacies Table 8. Global OTC Drug and Dietary Supplement Market Size Growth Rate (CAGR) by Region (US$ Million): 2021 VS 2025 VS 2032 Table 9. Global OTC Drug and Dietary Supplement Market Size by Region (2021-2026) & (US$ Million) Table 10. Global OTC Drug and Dietary Supplement Market Share by Region (2021-2026) Table 11. Global OTC Drug and Dietary Supplement Market Size by Region (2027-2032) & (US$ Million) Table 12. Global OTC Drug and Dietary Supplement Market Share by Region (2027-2032) Table 13. OTC Drug and Dietary Supplement Industry Trends Table 14. OTC Drug and Dietary Supplement Industry Drivers Table 15. OTC Drug and Dietary Supplement Industry Opportunities and Challenges Table 16. OTC Drug and Dietary Supplement Industry Restraints Table 17. Global OTC Drug and Dietary Supplement Revenue by Company (US$ Million) & (2021-2026) Table 18. Global OTC Drug and Dietary Supplement Revenue Market Share by Company (2021-2026) Table 19. Global OTC Drug and Dietary Supplement Players Revenue Ranking, 2024 VS 2025 VS 2026 Table 20. Global OTC Drug and Dietary Supplement Key Company Head Office and Area Served Table 21. Global OTC Drug and Dietary Supplement Company, Product Type & Application Table 22. Global OTC Drug and Dietary Supplement Company Establishment Date Table 23. Global Company Market Concentration Ratio (CR5 and HHI) Table 24. Global OTC Drug and Dietary Supplement by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue of 2025) Table 25. Global OTC Drug and Dietary Supplement Market Size by Type 2021 VS 2025 VS 2032 (US$ Million) Table 26. Global OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 27. Global OTC Drug and Dietary Supplement Market Size by Type (2027-2032) & (US$ Million) Table 28. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2021-2026) Table 29. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2027-2032) Table 30. Global OTC Drug and Dietary Supplement Market Size by Application 2021 VS 2025 VS 2032 (US$ Million) Table 31. Global OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 32. Global OTC Drug and Dietary Supplement Market Size by Application (2027-2032) & (US$ Million) Table 33. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2021-2026) Table 34. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2027-2032) Table 35. Abbott Company Information Table 36. Abbott Business Overview Table 37. Abbott OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 38. Abbott OTC Drug and Dietary Supplement Product Portfolio Table 39. Abbott Recent Development Table 40. Pfizer Company Information Table 41. Pfizer Business Overview Table 42. Pfizer OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 43. Pfizer OTC Drug and Dietary Supplement Product Portfolio Table 44. Pfizer Recent Development Table 45. GSK Company Information Table 46. GSK Business Overview Table 47. GSK OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 48. GSK OTC Drug and Dietary Supplement Product Portfolio Table 49. GSK Recent Development Table 50. Bayer Company Information Table 51. Bayer Business Overview Table 52. Bayer OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 53. Bayer OTC Drug and Dietary Supplement Product Portfolio Table 54. Bayer Recent Development Table 55. Suntory Company Information Table 56. Suntory Business Overview Table 57. Suntory OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 58. Suntory OTC Drug and Dietary Supplement Product Portfolio Table 59. Suntory Recent Development Table 60. Reckitt Benckiser Company Information Table 61. Reckitt Benckiser Business Overview Table 62. Reckitt Benckiser OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 63. Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio Table 64. Reckitt Benckiser Recent Development Table 65. Herbalife Company Information Table 66. Herbalife Business Overview Table 67. Herbalife OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 68. Herbalife OTC Drug and Dietary Supplement Product Portfolio Table 69. Herbalife Recent Development Table 70. Glanbia Company Information Table 71. Glanbia Business Overview Table 72. Glanbia OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 73. Glanbia OTC Drug and Dietary Supplement Product Portfolio Table 74. Glanbia Recent Development Table 75. Blackmores Company Information Table 76. Blackmores Business Overview Table 77. Blackmores OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 78. Blackmores OTC Drug and Dietary Supplement Product Portfolio Table 79. Blackmores Recent Development Table 80. Amway Company Information Table 81. Amway Business Overview Table 82. Amway OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026) Table 83. Amway OTC Drug and Dietary Supplement Product Portfolio Table 84. Amway Recent Development Table 85. North America OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 86. North America OTC Drug and Dietary Supplement Market Size by Type (2027-2032) & (US$ Million) Table 87. North America OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 88. North America OTC Drug and Dietary Supplement Market Size by Application (2027-2032) & (US$ Million) Table 89. North America OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 90. North America OTC Drug and Dietary Supplement Market Size by Country (2021-2026) Table 91. North America OTC Drug and Dietary Supplement Market Size by Country (2027-2032) Table 92. Europe OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 93. Europe OTC Drug and Dietary Supplement Market Size by Type (2027-2032) & (US$ Million) Table 94. Europe OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 95. Europe OTC Drug and Dietary Supplement Market Size by Application (2027-2032) & (US$ Million) Table 96. Europe OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 97. Europe OTC Drug and Dietary Supplement Market Size by Country (2021-2026) Table 98. Europe OTC Drug and Dietary Supplement Market Size by Country (2027-2032) Table 99. China OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 100. China OTC Drug and Dietary Supplement Market Size by Type (2027-2032) & (US$ Million) Table 101. China OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 102. China OTC Drug and Dietary Supplement Market Size by Application (2027-2032) & (US$ Million) Table 103. Asia OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 104. Asia OTC Drug and Dietary Supplement Market Size by Type (2027-2032) & (US$ Million) Table 105. Asia OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 106. Asia OTC Drug and Dietary Supplement Market Size by Application (2027-2032) & (US$ Million) Table 107. Asia OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 108. Asia OTC Drug and Dietary Supplement Market Size by Country (2021-2026) Table 109. Asia OTC Drug and Dietary Supplement Market Size by Country (2027-2032) Table 110. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2021-2026) & (US$ Million) Table 111. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2027-2032) & (US$ Million) Table 112. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2021-2026) & (US$ Million) Table 113. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2027-2032) & (US$ Million) Table 114. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032) & (US$ Million) Table 115. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021-2026) Table 116. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2027-2032) Table 117. Research Programs/Design for This Report Table 118. Authors List of This Report Table 119. Secondary Sources Table 120. Primary Sources List of Figures Figure 1. OTC Drug and Dietary Supplement Product Image Figure 2. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type, 2021 VS 2025 VS 2032 (US$ Million) Figure 3. Global OTC Drug and Dietary Supplement Market Share by Type: 2025 VS 2032 Figure 4. Powders Image Figure 5. Capsules Image Figure 6. Tablets Image Figure 7. Liquids Image Figure 8. Global OTC Drug and Dietary Supplement Market Size Growth Rate by Application, 2021 VS 2025 VS 2032 (US$ Million) Figure 9. Global OTC Drug and Dietary Supplement Market Share by Application: 2025 VS 2032 Figure 10. Convenience Stores Image Figure 11. Supermarkets Image Figure 12. Pharmacies Image Figure 13. Global OTC Drug and Dietary Supplement Market Size (US$ Million), 2021 VS 2025 VS 2032 Figure 14. Global OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 15. Global OTC Drug and Dietary Supplement Market Share by Region: 2025 VS 2032 Figure 16. Years Considered Figure 17. Global OTC Drug and Dietary Supplement Market Share by Players in 2025 Figure 18. Global Top 5 and 10 OTC Drug and Dietary Supplement Players Market Share by Revenue in 2025 Figure 19. Company Type (Tier 1, Tier 2, and Tier 3): 2021 VS 2025 Figure 20. Global OTC Drug and Dietary Supplement Market Size by Type (2021 VS 2025 VS 2032) & (US$ Million) Figure 21. Global OTC Drug and Dietary Supplement Revenue Market Share by Type (2021-2032) Figure 22. Global OTC Drug and Dietary Supplement Market Size by Application (2021 VS 2025 VS 2032) & (US$ Million) Figure 23. Global OTC Drug and Dietary Supplement Revenue Market Share by Application (2021-2032) Figure 24. North America OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 25. North America OTC Drug and Dietary Supplement Market Share by Type (2021-2032) Figure 26. North America OTC Drug and Dietary Supplement Market Share by Application (2021-2032) Figure 27. North America OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 28. United States OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 29. Canada OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 30. Mexico OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 31. Europe OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 32. Europe OTC Drug and Dietary Supplement Market Share by Type (2021-2032) Figure 33. Europe OTC Drug and Dietary Supplement Market Share by Application (2021-2032) Figure 34. Europe OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 35. Germany OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 36. France OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 37. U.K. OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 38. Italy OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 39. Russia OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 40. Nordic Countries OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 41. China OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 42. China OTC Drug and Dietary Supplement Market Share by Type (2021-2032) Figure 43. China OTC Drug and Dietary Supplement Market Share by Application (2021-2032) Figure 44. Asia OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 45. Asia OTC Drug and Dietary Supplement Market Share by Type (2021-2032) Figure 46. Asia OTC Drug and Dietary Supplement Market Share by Application (2021-2032) Figure 47. Asia OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 48. Japan OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 49. South Korea OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 50. Taiwan OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 51. Southeast Asia OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 52. India OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 53. Australia OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 54. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 55. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Share by Type (2021-2032) Figure 56. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Share by Application (2021-2032) Figure 57. South America, Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country (2021-2032) Figure 58. Brazil OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 59. South Africa OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 60. Saudi Arabia OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 61. Turkey OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 62. Argentina OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 63. UAE OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 64. Egypt OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 65. Chile OTC Drug and Dietary Supplement Market Size (2021-2032) & (US$ Million) Figure 66. Research Process Figure 67. Key Executives Interviewed

Scope & coverage.

Types
  • Powders
  • Capsules
  • Tablets
  • Liquids
Applications
  • Convenience Stores
  • Supermarkets
  • Pharmacies
Companies covered
  • Abbott
  • Pfizer
  • GSK
  • Bayer
  • Suntory
  • Reckitt Benckiser
  • Herbalife
  • Glanbia
  • Blackmores
  • Amway

Inside the report.

1 Market Overview
  1. 1.1 Product Definition
  2. 1.2 Market Analysis by Type
  3. 1.2.1 Global OTC Drug and Dietary Supplement Market Size Growth Rate by Type: 2021 VS 2025 VS 2032
  4. 1.2.2 Powders
  5. 1.2.3 Capsules
  6. 1.2.4 Tablets
  7. 1.2.5 Liquids
  8. 1.3 Market Analysis by Application
  9. 1.3.1 Global OTC Drug and Dietary Supplement Market Size Growth Rate by Application: 2021 VS 2025 VS 2032
  10. 1.3.2 Convenience Stores
  11. 1.3.3 Supermarkets
  12. 1.3.4 Pharmacies
  13. 1.4 Global Market Growth Prospects
  14. 1.5 Global OTC Drug and Dietary Supplement Growth Trends by Region
  15. 1.5.1 Global OTC Drug and Dietary Supplement Market Size by Region: 2021 VS 2025 VS 2032
  16. 1.5.2 OTC Drug and Dietary Supplement Market Size by Region (2021-2026)
  17. 1.5.3 OTC Drug and Dietary Supplement Market Size by Region (2027-2032)
  18. 1.6 Assumptions and Limitations
  19. 1.7 Study Goals and Objectives
  20. 1.8 Years Considered
2 Global OTC Drug and Dietary Supplement Market Dynamics
  1. 2.1 OTC Drug and Dietary Supplement Industry Trends
  2. 2.2 OTC Drug and Dietary Supplement Industry Drivers
  3. 2.3 OTC Drug and Dietary Supplement Industry Opportunities and Challenges
  4. 2.4 OTC Drug and Dietary Supplement Industry Restraints
3 Competitive Landscape by Company
  1. 3.1 Global OTC Drug and Dietary Supplement Revenue by Company (2021-2026)
  2. 3.2 Global OTC Drug and Dietary Supplement Players Revenue Ranking, 2024 VS 2025 VS 2026
  3. 3.3 Global OTC Drug and Dietary Supplement Key Company Head office and Area Served
  4. 3.4 Global OTC Drug and Dietary Supplement Company, Product Type & Application
  5. 3.5 Global OTC Drug and Dietary Supplement Company Establishment Date
  6. 3.6 Market Competitive Analysis
  7. 3.6.1 Global OTC Drug and Dietary Supplement Market CR5 and HHI
  8. 3.6.2 Global Top 5 and 10 OTC Drug and Dietary Supplement Players Market Share by Revenue in 2025
  9. 3.6.3 2025 OTC Drug and Dietary Supplement Tier 1, Tier 2, and Tier 3
4 OTC Drug and Dietary Supplement Market by Type
  1. 4.1 Global OTC Drug and Dietary Supplement Market Size by Type (2021 VS 2025 VS 2032)
  2. 4.2 Global OTC Drug and Dietary Supplement Market Size by Type (2021-2032)
  3. 4.3 Global OTC Drug and Dietary Supplement Market Size Share by Type (2021-2032)
5 OTC Drug and Dietary Supplement Market by Application
  1. 5.1 Global OTC Drug and Dietary Supplement Market Size by Application (2021 VS 2025 VS 2032)
  2. 5.2 Global OTC Drug and Dietary Supplement Market Size by Application (2021-2032)
  3. 5.3 Global OTC Drug and Dietary Supplement Market Size Share by Application (2021-2032)
6 Company Profiles
  1. 6.1 Abbott
  2. 6.1.1 Abbott Company Information
  3. 6.1.2 Abbott Business Overview
  4. 6.1.3 Abbott OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  5. 6.1.4 Abbott OTC Drug and Dietary Supplement Product Portfolio
  6. 6.1.5 Abbott Recent Developments
  7. 6.2 Pfizer
  8. 6.2.1 Pfizer Company Information
  9. 6.2.2 Pfizer Business Overview
  10. 6.2.3 Pfizer OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  11. 6.2.4 Pfizer OTC Drug and Dietary Supplement Product Portfolio
  12. 6.2.5 Pfizer Recent Developments
  13. 6.3 GSK
  14. 6.3.1 GSK Company Information
  15. 6.3.2 GSK Business Overview
  16. 6.3.3 GSK OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  17. 6.3.4 GSK OTC Drug and Dietary Supplement Product Portfolio
  18. 6.3.5 GSK Recent Developments
  19. 6.4 Bayer
  20. 6.4.1 Bayer Company Information
  21. 6.4.2 Bayer Business Overview
  22. 6.4.3 Bayer OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  23. 6.4.4 Bayer OTC Drug and Dietary Supplement Product Portfolio
  24. 6.4.5 Bayer Recent Developments
  25. 6.5 Suntory
  26. 6.5.1 Suntory Company Information
  27. 6.5.2 Suntory Business Overview
  28. 6.5.3 Suntory OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  29. 6.5.4 Suntory OTC Drug and Dietary Supplement Product Portfolio
  30. 6.5.5 Suntory Recent Developments
  31. 6.6 Reckitt Benckiser
  32. 6.6.1 Reckitt Benckiser Company Information
  33. 6.6.2 Reckitt Benckiser Business Overview
  34. 6.6.3 Reckitt Benckiser OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  35. 6.6.4 Reckitt Benckiser OTC Drug and Dietary Supplement Product Portfolio
  36. 6.6.5 Reckitt Benckiser Recent Developments
  37. 6.7 Herbalife
  38. 6.7.1 Herbalife Company Information
  39. 6.7.2 Herbalife Business Overview
  40. 6.7.3 Herbalife OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  41. 6.7.4 Herbalife OTC Drug and Dietary Supplement Product Portfolio
  42. 6.7.5 Herbalife Recent Developments
  43. 6.8 Glanbia
  44. 6.8.1 Glanbia Company Information
  45. 6.8.2 Glanbia Business Overview
  46. 6.8.3 Glanbia OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  47. 6.8.4 Glanbia OTC Drug and Dietary Supplement Product Portfolio
  48. 6.8.5 Glanbia Recent Developments
  49. 6.9 Blackmores
  50. 6.9.1 Blackmores Company Information
  51. 6.9.2 Blackmores Business Overview
  52. 6.9.3 Blackmores OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  53. 6.9.4 Blackmores OTC Drug and Dietary Supplement Product Portfolio
  54. 6.9.5 Blackmores Recent Developments
  55. 6.10 Amway
  56. 6.10.1 Amway Company Information
  57. 6.10.2 Amway Business Overview
  58. 6.10.3 Amway OTC Drug and Dietary Supplement Revenue and Gross Margin (US$ Million) & (2021-2026)
  59. 6.10.4 Amway OTC Drug and Dietary Supplement Product Portfolio
  60. 6.10.5 Amway Recent Developments
7 North America
  1. 7.1 North America OTC Drug and Dietary Supplement Market Size (2021-2032)
  2. 7.2 North America OTC Drug and Dietary Supplement Market Size by Type
  3. 7.2.1 North America OTC Drug and Dietary Supplement Market Size by Type (2021-2026)
  4. 7.2.2 North America OTC Drug and Dietary Supplement Market Size by Type (2027-2032)
  5. 7.2.3 North America OTC Drug and Dietary Supplement Market Share by Type (2021-2032)
  6. 7.3 North America OTC Drug and Dietary Supplement Market Size by Application
  7. 7.3.1 North America OTC Drug and Dietary Supplement Market Size by Application (2021-2026)
  8. 7.3.2 North America OTC Drug and Dietary Supplement Market Size by Application (2027-2032)
  9. 7.3.3 North America OTC Drug and Dietary Supplement Market Share by Application (2021-2032)
  10. 7.4 North America OTC Drug and Dietary Supplement Market Size by Country
  11. 7.4.1 North America OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032)
  12. 7.4.2 North America OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  13. 7.4.3 North America OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
  14. 7.4.4 North America OTC Drug and Dietary Supplement Market Share by Country (2021-2032)
  15. 7.4.5 United States
  16. 7.4.6 Canada
  17. 7.4.7 Mexico
8 Europe
  1. 8.1 Europe OTC Drug and Dietary Supplement Market Size (2021-2032)
  2. 8.2 Europe OTC Drug and Dietary Supplement Market Size by Type
  3. 8.2.1 Europe OTC Drug and Dietary Supplement Market Size by Type (2021-2026)
  4. 8.2.2 Europe OTC Drug and Dietary Supplement Market Size by Type (2027-2032)
  5. 8.2.3 Europe OTC Drug and Dietary Supplement Market Share by Type (2021-2032)
  6. 8.3 Europe OTC Drug and Dietary Supplement Market Size by Application
  7. 8.3.1 Europe OTC Drug and Dietary Supplement Market Size by Application (2021-2026)
  8. 8.3.2 Europe OTC Drug and Dietary Supplement Market Size by Application (2027-2032)
  9. 8.3.3 Europe OTC Drug and Dietary Supplement Market Share by Application (2021-2032)
  10. 8.4 Europe OTC Drug and Dietary Supplement Market Size by Country
  11. 8.4.1 Europe OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032)
  12. 8.4.2 Europe OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  13. 8.4.3 Europe OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
  14. 8.4.4 Europe OTC Drug and Dietary Supplement Market Share by Country (2021-2032)
  15. 8.4.5 Germany
  16. 8.4.6 France
  17. 8.4.7 U.K.
  18. 8.4.8 Italy
  19. 8.4.9 Russia
  20. 8.4.10 Nordic Countries
9 China
  1. 9.1 China OTC Drug and Dietary Supplement Market Size (2021-2032)
  2. 9.2 China OTC Drug and Dietary Supplement Market Size by Type
  3. 9.2.1 China OTC Drug and Dietary Supplement Market Size by Type (2021-2026)
  4. 9.2.2 China OTC Drug and Dietary Supplement Market Size by Type (2027-2032)
  5. 9.2.3 China OTC Drug and Dietary Supplement Market Share by Type (2021-2032)
  6. 9.3 China OTC Drug and Dietary Supplement Market Size by Application
  7. 9.3.1 China OTC Drug and Dietary Supplement Market Size by Application (2021-2026)
  8. 9.3.2 China OTC Drug and Dietary Supplement Market Size by Application (2027-2032)
  9. 9.3.3 China OTC Drug and Dietary Supplement Market Share by Application (2021-2032)
10 Asia (Excluding China)
  1. 10.1 Asia OTC Drug and Dietary Supplement Market Size (2021-2032)
  2. 10.2 Asia OTC Drug and Dietary Supplement Market Size by Type
  3. 10.2.1 Asia OTC Drug and Dietary Supplement Market Size by Type (2021-2026)
  4. 10.2.2 Asia OTC Drug and Dietary Supplement Market Size by Type (2027-2032)
  5. 10.2.3 Asia OTC Drug and Dietary Supplement Market Share by Type (2021-2032)
  6. 10.3 Asia OTC Drug and Dietary Supplement Market Size by Application
  7. 10.3.1 Asia OTC Drug and Dietary Supplement Market Size by Application (2021-2026)
  8. 10.3.2 Asia OTC Drug and Dietary Supplement Market Size by Application (2027-2032)
  9. 10.3.3 Asia OTC Drug and Dietary Supplement Market Share by Application (2021-2032)
  10. 10.4 Asia OTC Drug and Dietary Supplement Market Size by Country
  11. 10.4.1 Asia OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032)
  12. 10.4.2 Asia OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  13. 10.4.3 Asia OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
  14. 10.4.4 Asia OTC Drug and Dietary Supplement Market Share by Country (2021-2032)
  15. 10.4.5 Japan
  16. 10.4.6 South Korea
  17. 10.4.7 Taiwan
  18. 10.4.8 Southeast Asia
  19. 10.4.9 India
  20. 10.4.10 Australia
11 South America, Middle East & Africa
  1. 11.1 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size (2021-2032)
  2. 11.2 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type
  3. 11.2.1 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2021-2026)
  4. 11.2.2 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Type (2027-2032)
  5. 11.2.3 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Share by Type (2021-2032)
  6. 11.3 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application
  7. 11.3.1 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2021-2026)
  8. 11.3.2 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Application (2027-2032)
  9. 11.3.3 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Share by Application (2021-2032)
  10. 11.4 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country
  11. 11.4.1 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021 VS 2025 VS 2032)
  12. 11.4.2 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2021-2026)
  13. 11.4.3 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Size by Country (2027-2032)
  14. 11.4.4 South America, Middle East & Africa OTC Drug and Dietary Supplement Market Share by Country (2021-2032)
  15. 11.4.5 Brazil
  16. 11.4.6 South Africa
  17. 11.4.7 Saudi Arabia
  18. 11.4.8 Turkey
  19. 11.4.9 Argentina
  20. 11.4.9 UAE
  21. 11.4.9 Egypt
  22. 11.4.9 Chile
12 Concluding Insights
    13 Appendix
    1. 13.1 Reasons for Doing This Study
    2. 13.2 Research Methodology
    3. 13.3 Research Process
    4. 13.4 Authors List of This Report
    5. 13.5 Data Source
    6. 13.5.1 Secondary Sources
    7. 13.5.2 Primary Sources
    8. 13.6 Disclaimer

    GET THE RESEARCH

    Choose your license.

    Choose who needs access.
    All options are for this report and research series.

    Compare access permissions.

    Single User License
    One named user. Individual access.
    Multi User License
    Up to 5 users in the same department.
    Enterprise License
    Organization-wide access within the agreed license.

    Access applies to the purchased edition. Later editions are separate purchases.

    License options
    $3,950USD
    Buy now

    PDF by email within 3–5 working days after payment confirmation.

    Talk to an analyst
    APO Research
    Talk to an analyst